Chinese biopharma firm Gensciences rakes in $124m in Series A, B rounds

Chinese biopharma firm Gensciences rakes in $124m in Series A, B rounds

Chinese biopharmaceutical firm Gensciences has raked in a total of over 800 million yuan ($123.6 million) through its Series A and Series B rounds of financing as the life science sector is gaining more traction during the global health crisis.

Investors in the Series A round include investment companies IDG Capital, New Alliance Capital, and Huaige Capital. The Series A backers made follow-on investments in the subsequent Series B round as well.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter